Objectives. The overexpression of IL-12 family cytokines is implicated in the pathogenesis of SSc, but their exact role is still unclear. The aim of this study was to investigate the regulation of extracellular matrix expression by IL-23 and its contribution to the phenotype of SSc.
Introduction
SSc is an autoimmune disorder characterized by tissue fibrosis of the skin and internal organs. Although the pathogenesis of this disease is still unclear, inflammation, autoimmune attack and vascular damage may lead to the activation of fibroblasts and the abnormal accumulation of extracellular matrix (ECM), mainly collagen [1, 2] . Thus, abnormal SSc fibroblasts responsible for the fibrosis may develop from cells that have escaped from normal control mechanisms [3, 4] .
Although the mechanism of fibroblast activation in SSc is unknown, many of the characteristics found in SSc fibroblasts resemble those in healthy fibroblasts stimulated by TGF-b1 [5, 6] . The principal effect of TGF-b1 on fibroblasts is induction of ECM deposition. Fibroblasts cultured from affected SSc skin in vitro can produce excessive amounts of collagens [7, 8] , indicating that the activation of dermal fibroblasts in SSc may be a result of stimulation by TGF-b1 signalling. This notion is supported by the finding that the phosphorylated levels and DNAbinding activity of Smad3, an intracellular signalling molecule of TGF-b1, are constitutively up-regulated in SSc fibroblasts [9] . In addition, other cytokines, including connective tissue growth factor (CTGF), PDGF and insulin-like growth factor, IL-1, IL-6 or IL-7, have also been reported to be involved in the pathogenesis of this disease [1014] . Thus, clarifying the cytokine network mediating fibroblast activation as well as the inflammation, autoimmune disorder and vascular damage of SSc may be important to understand the molecular mechanisms of this disease and to develop a new therapeutic strategy.
The IL-12 family includes IL-12, IL-23 and IL-27. There are several reports investigating their serum concentrations in SSc patients. For example, IL-12 concentrations were significantly elevated in patients with SSc compared with healthy controls [15] . In addition, the serum concentration of IL-23 or IL-27 is also reported to be increased in the sera of SSc patients [16, 17] . However, their clinical significance has not been clarified.
In the present study, we investigated the effect of the IL-12 family on ECM expression in normal fibroblasts. In addition, we demonstrated the involvement of IL-23 signalling in the abnormal ECM overexpression seen in SSc.
Methods

Patients
Patients with SSc were grouped according to the classification system proposed by LeRoy et al. [18] . All patients fulfilled the criteria proposed by the ACR [19] . Skin biopsy specimens of SSc patients were obtained from lesional skin. Control skin samples were obtained from routinely discarded skin of healthy human subjects who were undergoing skin grafting [20] .
Institutional review board approval and written informed consent were obtained before patients and healthy volunteers were entered into this study, according to the Declaration of Helsinki.
Cell cultures
Human dermal fibroblasts were obtained by skin biopsy from the affected areas (dorsal forearm) of five patients with diffuse cutaneous SSc and <2 years of skin thickening as described previously [21] . Control fibroblasts were obtained from skin biopsy specimens of five healthy donors. According to the Declaration of Helsinki, institutional review board approval and written informed consent were obtained. Primary explant cultures were established in 25 cm 2 culture flasks in modified Eagle's medium supplemented with 10% fetal calf serum and antibioticantimycotic (Invitrogen, Carlsbad, CA, USA). Monolayer cultures were maintained at 37 C in 5% CO 2 in air. Fibroblasts between the third and sixth subpassages were used for experiments. Before experiments, cells were serum starved for 24 h.
Cell lysis and immunoblotting
Fibroblasts were cultured until they were subconfluent, and the medium was collected. The remaining cells were washed with cold PBS twice and lysed in Denaturing Cell Extraction Buffer (Biosource, Camarillo, CA, USA). Aliquots of the cell lysates or conditioned medium were subjected to electrophoresis on 10% SDSpolyacrylamide gels and transferred onto polyvinylidene fluoride (PVDF) filters. The PVDF filters were then incubated with antibody against IL-23 receptor (IL-23R; IMGENEX, San Diego, CA, USA), type I collagen (Southern Biotech, Birmingham, AL, USA), CTGF (Abcam, Cambridge, UK) or b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Then the filters were incubated with secondary antibody, and the immunoreactive bands were visualized using the ECL system (Amersham Biosciences, Arlington Heights, IL, USA) according to the manufacturer's recommendations. The densities of the bands were measured using Quantity One 1D analysis software version 4.6.6 on the ChemiDoc TM XRS System (Bio-Rad Laboratories, Hercules, CA, USA).
Immunohistochemistry
Wax-embedded sections (4 mm thick) were dewaxed in xylene and rehydrated in graded alcohols. For immunostaining, antigens were retrieved by incubation with citrate buffer pH 9.0 for 5 min with autoclaving. Endogeneous peroxidase activity was inhibited with a solution of 1% hydrogen peroxide in methyl alcohol, after which sections were blocked with 5% donkey serum for 20 min and then reacted with antibody for IL-23 (1:100 dilution; Abcam) or IL-23R (1:50 dilution) for 24 h at 4 C. After excess antibody had been washed out with PBS, samples were incubated with horseradish peroxidase-labelled anti-rabbit antibody (Nichirei, Tokyo, Japan) for 30 min at 37 C. The reactions were visualized using the diaminobendine substrate system (Dojin, Kumamoto, Japan). The slides were counterstained with Mayer's haematoxylin and examined under a light microscope (Olympus BX50, Tokyo, Japan).
Intradermal treatment with bleomycin and IL-23
Bleomycin (Nippon Kayaku, Tokyo, Japan) was dissolved in PBS at a concentration of 1 mg/ml. Then, bleomycin or PBS (100 ml) was injected intradermally into the shaved back of 7-week-old BALBc mice daily for 4 weeks, as described previously [22, 23] . The back skin was removed on the next day after the final injection, fixed in 10% formalin solution and embedded in paraffin. All animal experimental protocols in this study were approved by the Committee on Animal Research at Kumamoto University.
Dermal thickness was evaluated by measuring the distance between the epidermaldermal junction and the dermalfat junction in haematoxylin-and eosin-stained sections.
RNA isolation and quantitative real-time PCR Total RNA was extracted from cultured cells using ISOGEN (Nippon Gene, Tokyo, Japan) according to the protocol. The RNA isolation from skin tissues was performed using a miRNeasy FFPE kit (Qiagen, Hilden, Germany).
For the PCR array, first-strand cDNA was synthesized using an RT For the quantitative real-time PCR, first-strand cDNA was synthesized using a PrimeScript RT reagent Kit (Takara) with both oligodT primer and random hexamers. GAPDH primer was purchased from SABiosciences, and the primer set for IL-23R was from Takara. One microlitre of diluted first-strand cDNA product was used for amplification in a 25 ml reaction solution containing 12.5 ml of SYBR Premix Ex Taq II (Takara) and 1 ml of each primer. DNA was amplified for 40 cycles of denaturation for 15 s at 95 C, annealing for 35 s at 55 C and extension for 30 s at 72 C, with Takara Thermal Cycler Dice (TP800). The specificity of reactions was determined by melting curve analysis. The relative expression of each gene was calculated by the standard curve method. For each gene of interest, we performed at least three independent experiments.
RT and PCR analysis of miRNA cDNA synthesis from total miRNA was performed using a Mir-X TM miRNA First-Strand Synthesis Kit (Takara). The sequences of miRNA primers were designed based on miRBase (http://www.mirbase.org). PCR was performed on Takara Thermal Cycler Dice. DNA was amplified for 40 cycles of denaturation for 5 s at 95 C and annealing for 20 s at 60 C. Data generated from each PCR were analysed using Thermal Cycler Dice Real Time System ver2.10B. Transcript levels of each miRNA were normalized to U6.
Transient transfection miScript miRNA mimics or inhibitors were obtained from Qiagen. For reverse transfection, miRNA mimics or inhibitors mixed with Lipofectamine RNAiMAX (Invitrogen) were added when cells were plated, followed by incubation for 12 h (for real-time PCR) or 72 h (for immunoblotting) at 37 C in 5% CO 2 . Control experiments showed >80% of transfection efficiency (data not shown).
Collagen assay
The amount of collagen in paraffin sections was quantified using a Semi-Quantitative Collagen Assay Kit (Chondrex, Redmond, WA, USA). After dewaxing in xylene and rehydration in graded alcohols, sections (20 mm in thickness) were immersed in staining solution at room temperature for 30 min. The staining solution was removed, and the bleaching solution was added to measure the absorbance at 540 and 605 nm in an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). The collagen concentration was calculated based on the following formula: Collagen (mg/section) = (OD 540 (OD 605 Â 0.291))/37.8 Â 1000 [24] .
Statistical analysis
Data are expressed as the means (S.D.) of at least three independent experiments. Statistical analysis was carried out with the MannWhitney U-test for the comparison of means. Values of P < 0.05 were considered significant.
Results
The effect of IL-12, IL-23 or IL-27 on type I collagen expression in normal fibroblasts
As an initial experiment, we examined the effect of IL-12 families on type ? collagen protein expression in normal dermal fibroblasts. As shown in Fig. 1A , IL-12 did not change the expression levels of type I collagen. The collagen expression was inhibited by IL-23 in a dose-dependent manner, and was slightly increased by IL-27. Next, we performed a PCR array to analyse the change of expression pattern of ECM-related genes by these cytokines (Table 1 ; the complete data set is available at www.ncbi.nlm.nih.gov/geo/, GSE78838). The effects of IL-12, IL-23 or IL-27 on COL1A2 mRNA expression were <2-fold, compared with untreated cells. Then we focused on the possibility that IL-23 down-regulates collagen protein expression without changing its mRNA level. The steady-state level of protein is controlled by the level of protein translation and/or the stability of protein. To examine whether IL-23 decreases type I collagen protein expression by changing protein degradation activity, de novo protein synthesis was blocked with cycloheximide, and half-lives of collagen protein in the presence or absence of IL-23 were determined by immunoblotting (Fig. 1B) . The half-lives of existing type I collagen in cell lysates were not affected by IL-23. In addition, after cycloheximide treatment, the amount of secreted collagen in the culture media was also decreased in cells treated with or without IL-23 to the similar extent. Thus, IL-23 signalling may decrease collagen protein without changing mRNA levels and the protein half-lives.
We hypothesized that miRNAs are involved in this process, because miRNAs usually inhibit translation of their target genes and can have an effect on target protein expression without changing mRNA levels or protein halflives. miRNAs targeting both COL1A1 and COL1A2 were predicted using TargetScan (version 6.2, http://www.targetscan.org/). Among them, only the miR-4458 levels were significantly increased by the treatment with IL-23 in comparison with untreated cells (Fig. 1C) . Thus, IL-23 may decrease type I collagen protein levels via miR-4458 induction. Consistent with this hypothesis, the transfection of miR-4458 mimic in normal fibroblasts down-regulated protein levels of type I collagen (Fig. 1D) . In contrast, forced down-regulation of miR-4458 by its inhibitor did www.rheumatology.oxfordjournals.org not increase type I collagen expression, suggesting that miR-4458 expression level was low enough in normal fibroblasts.
The function of miR-4458 in SSc fibroblasts As described in the Introduction, TGF-b is the one of the key signals in the pathogenesis of SSc. The mean transcript level of miR-4458 was up-regulated both in normal fibroblasts stimulated by the ectopic TGF-b and in untreated SSc fibroblasts compared with untreated normal cells ( Fig. 2A) , suggesting that miR-4458 up-regulation in SSc fibroblasts is attributable to intrinsic activation of TGF-b. TGF-b stimulation increased miR-4458 expression in SSc fibroblasts only slightly, probably because the TGF-b signal had already been saturated.
Serum IL-23 has been reported to be elevated in SSc patients [16] . We then tried to clarify the roles of IL-23 and miR-4588 in SSc cells; IL-23 also induced miR-4458 expression in SSc fibroblasts (Fig. 2B) . Unlike normal fibroblasts, however, IL-23 up-regulated protein expression of type I collagen in SSc fibroblasts (Fig. 2C) . In addition, the inhibitory effect of miR-4458 mimic on type I collagen expression in SSc fibroblasts was weaker than that in normal   FIG. 1 The effect of IL-23 on collagen protein expression in cultured normal dermal fibroblasts (A) Normal fibroblasts were incubated in the presence or absence of the indicated cytokines for 72 h (n = 3). (B) Left panel, confluent quiescent cells were incubated in the presence or absence of IL-23 (100 ng/ml) for 24 h before the addition of cycloheximide (10 mg/ml). Right panel, cells and conditioned media were harvested after cycloheximide was administered. The levels of cell-associated collagen were quantified by scanning densitometry. (C) Normal fibroblasts were incubated in the presence or absence of IL-23 (100 ng/ml), and total miRNA was extracted. P < 0.05. (D) Normal fibroblasts were treated with miR-4458 mimic (left) or inhibitor (right) (n = 3).
fibroblasts ( Figs 1D and 2D) , probably because miR-4458 is already saturated. In contrast, miR-4458 inhibitor induced collagen expression in SSc fibroblasts (Fig. 2D ), but not in normal fibroblasts (see Fig. 1D ); this may be because miR-4458 is increased only in SSc fibroblasts.
miR-18a is another mediator of IL-23
We hypothesized that a balance between miR-4458 and another miRNA may be involved in the paradoxical effects of IL-23 on collagen expression between normal and SSc fibroblasts. As shown in Fig. 1C , the expressions of miRNAs directly targeting type I collagen were not altered by IL-23 except for miR-4458. We determined other miRNAs and found that miR-18a was down-regulated by IL-23 stimulation slightly but significantly in normal fibroblasts (Fig. 3A) . miR-18a has already been shown to target CTGF, a cytokine that induces tissue fibrosis and is implicated in the pathogenesis of SSc [10] . IL-23 also reduced miR-18a expression in SSc fibroblasts (Fig. 3B) . miR-18a expression was slightly but significantly down-regulated both in TGF-b-treated normal fibroblasts and in unstimulated SSc fibroblasts compared with untreated normal cells (Fig. 3C) , suggesting that miR-18a down-regulation in SSc fibroblasts is attributable to intrinsic activation of TGF-b. Immunoblotting showed that miR-18a mimic down-regulated protein expression of type I collagen and CTGF both in normal fibroblasts and in SSc fibroblasts (Fig. 3D) . Therefore, miR-18a has an anti-fibrogenic effect by the down-regulation of CTGF and collagen. Taken together, the balance between miR-4458 and miR-18a can explain the opposite effects of IL-23 on collagen expression in normal and SSc fibroblasts. As shown in supplementary Fig. S1 , available at Rheumatology Online, miR-4458 and miR-18a target type I collagen and CTGF, respectively, and both miRNAs have an inhibitory effect on collagen expression.
In normal fibroblasts, extrinsic IL-23 stimulation increases miR-4458 expression strongly while it reduces miR-18a expression slightly, which results in the down-regulation of collagen expression. On the contrary, TGF-b stimulation increases miR-4458 expression slightly and decreases miR-18a expression slightly, which offset each other; TGF-b induces collagen expression directly via Smads.
The serum concentrations of IL-23 are reported to be increased in SSc patients [16] . Furthermore, in SSc fibroblasts, autocrine TGF-b activation stimulates collagen production. Simultaneous stimulation with endogenous IL-23 and TGF-b increases miR-4458 expression strongly and decreases miR-18a expression strongly. Given that the suppressive effect of miR-4458 on collagen expression becomes saturated, the effects of miR-4458 and miR-18a also offset each other. Extrinsic IL-23 stimulation in SSc fibroblasts further increases miR-4458 and decreases miR-18a. However, because the suppressive effect of miR-4458 on collagen expression has already been saturated, a further increase of miR-4458 did not affect the collagen expression. Accordingly, the extrinsic IL-23 treatment may result in the collagen up-regulation in   FIG. 2 The effect of IL-23 on the expression of miRNAs and collagen in cultured SSc fibroblasts (A) Normal and SSc fibroblasts were incubated in the presence or absence of TGF-b (2 ng/ml) for 12 h. The relative levels of miR-4458 were determined by quantitative real-time PCR (n = 3). P < 0.05. (B) SSc fibroblasts were incubated in the presence or absence of IL-23 (100 ng/ml). Mean relative transcript levels of miR-4458 expression levels were determined (n = 5). (C) SSc fibroblasts were incubated in the presence or absence of IL-23 (100 ng/ml). Cell lysates were subjected to immunoblotting with antibody for type I collagen (n = 3). (D) SSc fibroblasts were treated with miR-4458 mimic (left) or inhibitor (right) (n = 3).
SSc dermal fibroblasts because of further miR-18a downregulation.
IL-23 and IL-23R expression in SSc fibroblasts in vivo
We performed immunohistochemical staining of IL-23 p19 subunit using paraffin-embedded skin sections derived from SSc patients and healthy donors. In SSc skin, the expression of IL-23 was increased in infiltrated cells compared with normal skin (Fig. 4A) . Therefore, IL-23 is likely to be increased not only in serum but also in affected skin of SSc patients.
In contrast, although there has been no previous report describing IL-23R in dermal fibroblasts, immunoblotting revealed that IL-23R was expressed in cultured normal and SSc fibroblasts to a similar extent (Fig. 4B ) in vitro. Also, immunostaining showed that IL-23R was expressed in fibroblast-like spindle-shaped cells of normal and SSc skin in vivo (Fig. 4C) . Thus, dermal fibroblasts have IL-23R, and its expression levels are likely to be similar in normal and SSc fibroblasts.
Taking the results together, IL-23 may have an inducible effect on the collagen expression only in SSc fibroblasts, and the up-regulation of IL-23 levels in SSc skin and sera in vivo contributes to the increased collagen accumulation and tissue fibrosis.
IL-23 induced dermal fibrosis in bleomycin-treated mice in vivo
Skin fibrosis induced by bleomycin injection in mice is used as a murine model of SSc [22] . Lastly, we tried to clarify the effect of IL-23 on collagen protein expression and dermal fibrosis in vivo, using the SSc mouse model .   FIG. 3 The effects of IL-23 on the expression of miR-18a and connective tissue growth factor (A) Normal fibroblasts were incubated in the presence or absence of IL-23 (100 ng/ml). Relative expression levels of miR18a were determined (n = 5). (B) SSc fibroblasts were incubated in the presence or absence of IL-23 (100 ng/ml). Relative expression levels of miR-18a were determined (n = 5). (C) Normal and SSc fibroblasts were incubated in the presence or absence of TGF-b (2 ng/ml). Total miRNA was extracted, and the relative levels of miR-18a were determined (n = 5). (D) Normal and SSc fibroblasts were transfected with miR-18a mimic (upper panels) or inhibitor (lower panels). Cell lysates were subjected to immunoblotting (n = 3). CTGF: connective tissue growth factor.
www.rheumatology.oxfordjournals.org Bleomycin or control PBS was locally injected in the back of the BALB/c mice six times per week for a month and, at the same time, control PBS or IL-23 were also injected once per week (four times a month; Fig. 5A ). Haematoxylin and eosin staining showed that the dermal thickness of the mouse skin was decreased by IL-23 injection in the absence of bleomycin treatment (Fig. 5B) . In contrast, the dermal thickness of bleomycin-treated mouse skin was increased by IL-23 injection compared with PBS injection (Fig. 5B) , and the increase was statistically significant (Fig. 5C) . Consistently, the amount of collagen content in the skin tissue section was also increased in IL-23-injected mouse skin in the presence of bleomycin treatment (Fig. 5C ). Taken together, these data indicate that IL-23 could accelerate the skin fibrosis induced by bleomycin in vivo, which is compatible with the notion that IL-23 increases collagen expression only in SSc fibroblasts in vitro. It is noteworthy that miR-4458 levels were slightly induced whereas miR-18a levels were reduced by IL-23 in the presence of bleomycin treatment (Fig. 5D) , which was also consistent with in vitro results.
Discussion
The present study first described a new miRNAtarget interaction; miR-4588 targets type I collagen in dermal fibroblasts. There have been a lot of reports demonstrating that miRNAs contribute to the skin fibrosis   FIG. 4 The expression of IL-23 and the receptor in SSc skin (A) Paraffin-embedded sections were subjected to immunohistochemical analysis for IL-23p19 as described in the Methods section. Scale bar = 100mm. One experiment representative of three independent experiments is shown. (B) Normal and SSc fibroblasts were cultured independently in the same conditions. Cell lysates were subjected to immunoblotting with antibody for IL-23 receptor (IL-23R). The same membrane was reprobed with anti-b-actin antibody to show loading controls. Representative results using three normal and three SSc fibroblasts are shown. (C) Paraffinembedded sections of normal and SSc skin were stained with antibodies against IL-23R. Arrows indicate spindle cells. One experiment representative of three independent experiments is shown. Scale bar = 100 mm (right), 200 mm (left).
of SSc. For example, miR-196a also regulates type I collagen, and its down-regulation in the skin and fibroblasts of SSc induces collagen overexpression [25] . let-7a is also one of the miRNAs targeting collagen, and the injection of let-7a prevented the skin fibrosis induced by bleomycin in mice [26] . However, most of the reports investigated the role of a single miRNA. Determining only one of more than 2000 miRNAs may be less significant for addressing the pathogenesis of SSc, and there is a possibility that the interaction of multiple miRNAs may be involved in the aetiology of the disease. We reported recently that a combination of the serum concentrations of multiple miRNAs was useful for the diagnosis of SSc [27] . The present study is the first to demonstrate that the balance of two miRNAs mediates the mechanism of fibrosis in SSc.
IL-23 is mainly produced by the antigen-presentation dendritic cells and macrophages. In addition, immunohistochemical analyses have revealed that IL-23 is also expressed in keratinocytes of psoriasis skin [28] . Notably, collagen synthesis is thought to be increased in psoriasis skin [29] . It is possible that keratinocyte IL-23 may also contribute to the collagen metabolism in psoriasis by stimulating dermal fibroblasts. Many reports have indicated that IL-23 is essential for the differentiation of Th17 lymphocytes [3032] . We previously reported that IL-17 levels are increased in sera and the involved skin of SSc [33] , which is consistent with the present study. It is noteworthy that IL-17A also reduces CTGF expression [33] . Thus, CTGF is thought to play an important role in the mechanism of fibrosis of SSc [10] , probably under the control of IL-23 or IL-17A.
Furthermore, our study showed that bleomycin-induced skin fibrosis was accelerated by IL-23 injection in vivo. Levels of miR-4458 and miR-18a were linked to the extent of skin fibrosis. These data are compatible with the notion that IL-23 increases collagen expression only in SSc fibroblasts in vitro. Taken together, our results indicate possible therapeutic values of anti-IL-23 treatment against the fibrotic condition of SSc and possible usefulness of miRNA levels as markers for the fibrosis.
A limitation of this study is that we did not demonstrate the effect of miR-18a inhibition on CTGF and collagen levels in dermal fibroblasts. Further studies to clarify the regulatory mechanism of tissue fibrosis by IL-23 in SSc skin may lead to a better understanding of this disease and new therapeutic approaches.
